MUMBAI Feb 5 Lupin Ltd, India's third-largest drugmaker, reported a 12 percent fall in third-quarter profit that was in line with analysts' expectations. Net profit for the quarter ended Dec. 31 was 5.30 billion rupees ($78.3 million), down from ... Reuters India, 5 days ago
Lupin falls ahead of earnings - Sify, 5 days ago
Lupin Q3 net profit likely to fall - India Infoline, 6 days ago
3 images for "lupin ltd"
Shares of pharmaceutical major Lupin Ltd recovered and ended the session higher by 9.04 per cent at Rs 1,801.45 on the BSE. Earlier, the stock plunged 2.8 per cent ahead of October-December quarter earnings. The results were expected during market hours.Business Line, 5 days ago Lupin ends in red despite FDA nod for chewable contraceptive India Infoline, 1 month ago Lupin gets FDA nod for Generic Generess tablets India Infoline, 1 month ago Lupin gets USFDA nod for generic Generess tablets HT Syndication, 1 month ago
Lupin Ltd expects to obtain 25 product approvals from the US Food and Drug Administration (FDA) in 2015-2016. The company has reported a net profit of Rs529 crore for Oct-Dec 2015 (Rs601 crore for Oct-Dec 2014). Its total revenue has gone up to ...Pharmacy Choice, 2 days ago LUPIN : Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug 4 Traders, 2 weeks ago 1/27/16 - Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug [India Infoline News Service] Pharmacy Choice, 2 weeks ago Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug [India Infoline News Service] Pharmacy Choice, 2 weeks ago
The past few quarters had seen Lupin's results disappoint, particularly on sales growth in the US. This quarter did not The sharp decline in Lupin Ltd's share price since January appears to have set the stage for a smart recovery post-results. The ...Livemint.com, 2 days ago
NEW DELHI: Drug firm Lupin has launched its Metformin HCl tablets, a diabetes drug, in the US market and is eligible for 180 days exclusivity for the product. "The company's US subsidiary Lupin Pharmaceuticals Inc has launched its Metformin HCl ...Economic Times, 1 week ago
Feb. 09--HYDERABAD -- Aurobindo Pharma Ltd is planning a major push to launch high-margin anti-cancer and hormone drugs, targeting a revenue of $3 billion in the next two years. In a recent investor presentation, the company said it is working on ...Bloomberg, 1 day ago
Takeaway: If a patent owner is opposing joinder, it needs to show how it will be unduly burdened by the joinder. In its Decision , the Board granted inter partes review of challenged claims 1-22 of the 431 Patent and granted joinder with ...National Law Review, 6 days ago
(Bloomberg) -- Indian stocks declined for a second day and the currency weakened as renewed concern about the health of the global economy sparked a worldwide selloff. Tata Consultancy Services Ltd. and Infosys Ltd., the nation's largest software ...La Repubblica, 1 day ago
India stocks were lower after the close on Tuesday, as losses in the IT, Technology and Metals sectors led shares lower. At the close in NSE, the Nifty 50 fell 1.21%, while the BSE Sensex 30 index fell 1.10%. The best performers of the session ...Investing.com, 1 day ago India stocks higher at close of trade; Nifty 50 up 1.15% Investing.com, 5 days ago
When two of the world's biggest pharmaceutical companies announced a tie-up in Japan, the country's $78 billion drug industry took note. In November, the country's largest drugmaker, Takeda Pharmaceutical Co., said itd separate its off-patent ...Bloomberg, 3 days ago
on your WebpageAdd Widget >Get your members hooked!